ISCO — Stock activity · TradeandTell
ISCO ISCO $0.18 -$0.01 (-3.52%) prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$0.11 – $0.27
42% from low
Financials Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
Income Balance sheet Cash flow
2018 2019 2020 2021 2022 2023 2024 2025 $11.1M $9.5M $7.1M $7.2M $8.2M $7.8M $9.1M $9.1M $4.1M $3.9M $2.8M $2.9M $3.3M $3.2M $3.8M $4.0M $7.0M $5.5M $4.3M $4.2M $4.9M $4.6M $5.3M $5.1M 63.3% 58.5% 61.0% 59.1% 60.0% 59.2% 58.6% 55.7% $2.4M $1.4M $988.0K $695.0K $492.0K $511.0K $657.0K $684.0K −$3.5M −$5.7M −$2.8M −$1.9M −$196.0K −$663.0K −$68.0K −$267.0K −$1.8M −$3.9M −$2.4M −$220.0K $22.0K $202.0K $142.0K −$48.0K −$2.1M −$4.3M −$2.8M −$1.0M −$466.0K −$131.0K −$209.0K −$418.0K -19.2% -45.9% -39.8% -14.5% -5.7% -1.7% -2.3% -4.6% -0.33 -0.58 -0.38 -0.13 -0.06 -0.02 -0.03 -0.05
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus) Year Est. revenue Est. EPS EPS range # Analysts 2026 $7M $-0.72 $-0.72–$-0.72 1 2027 $11M $-0.32 $-0.32–$-0.32 1 2028 $10M $-0.54 $-0.54–$-0.54 1 2029 $11M $-1.16 $-1.16–$-1.16 1
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate Peer comparison Symbol Price Today Mkt cap P/E ISCO International Stem Cell Corporation $0.18 +0.00% $1M — BICTF Biocure Technology Inc. $0.01 +0.00% $379088 — BIOR Biora Therapeutics, Inc. $0.22 +0.00% $994994 — BMNDF Biomind Labs Inc. $0.12 +0.00% $9M — CAIHF Chia Tai Enterprises International Limited $0.28
Held by traders on TradeandTell No one on the platform currently holds ISCO.
Super investors & insiders Institutions holding (13F)
No tracked institution reports a position in ISCO as of their last filing.
Insider activity (SEC Form 4)
Stock splits Execution date Ratio 2015-07-29 1-for-150reverse 2006-11-21 4.42-for-1
Recent trades on TradeandTell No one on the platform has traded ISCO yet.
Report a bug DTRK DATATRAK International, Inc. $0.18 +0.00% $230040 —
EVFM Evofem Biosciences, Inc. $0.01 +0.00% $1M —
Source: Financial Modeling Prep · peers by sector/industry
Valuation Trading at 0.2× sales vs its 0.2× historical median P/S.
Fair value ≈ $0.17 · price $0.18 today
Fair value · 2% above Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Insider activity (SEC Form 4)
Form 4 filed Jun 23, 2026 ↗ Form 4 filed Jun 23, 2026 ↗ Form 4 filed Jun 20, 2025 ↗ Form 4 filed Jun 20, 2025 ↗ Form 4 filed Jun 13, 2024 ↗ Form 4 filed Jun 13, 2024 ↗ Form 4 filed Nov 8, 2023 ↗ Form 4 filed Nov 8, 2023 ↗ Form 4 filed Jun 16, 2023 ↗ Form 4 filed Jun 16, 2023 ↗ Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$ISCO chatter on StockTwits I found you a MACD Bearish Reversal Divergence on the daily chart of International Stem Cell Corp. $ISCO #BearishReversalDivergence #OTCQB
View on StockTwits ↗ $ISCO P/S is 89% below its last 4 quarters average of 0.7: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO EV/Sales is 46% below its last 4 quarters average of 1.2: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO P/S is 91% below its last 4 quarters average of 0.7: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO EV/Sales is 42% below its last 4 quarters average of 1.2: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO P/S is 90% below its last 4 quarters average of 0.7: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO P/S is 90% below its last 4 quarters average of 0.7: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO P/S is 89% below its last 4 quarters average of 0.7: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO EV/Sales is 47% below its last 4 quarters average of 1.2: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO P/S is 89% below its last 4 quarters average of 0.7: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO EV/Sales is 43% below its last 4 quarters average of 1.2: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO P/S is 83% below its last 4 quarters average of 0.7: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO EV/Sales is 44% below its last 4 quarters average of 1.2: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO P/S is 81% below its last 4 quarters average of 0.7: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ $ISCO EV/Sales is 43% below its last 4 quarters average of 1.2: https://fullratio.com/stocks/otc-isco/international-stem-cell
View on StockTwits ↗ Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
